SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that Dr Michael Baker is presenting at the Finance News Network Virtual Investor Event on 17 November, 2020.
A copy of the Investor Presentation follows.
For more information, download the attached PDF.
Download this document
